NCT05634941

Brief Summary

So far, antidepressant drugs have limited memory improvement. Transcranial direct current stimulation, as a non-invasive and safe neuroregulatory technique, is a new direction to improve memory.In this study, transcranial direct current stimulation of the greater occipital nerve was used to explore the effect of improving memory function in patients with stable depression, and related studies were conducted on the locus coeruleus-noadrenal loop and the functional connection between locus coeruleus, hippocampus and amygdala.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 2, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

December 2, 2022

Status Verified

November 1, 2022

Enrollment Period

1.2 years

First QC Date

November 22, 2022

Last Update Submit

November 22, 2022

Conditions

Keywords

Depressiontranscranial direct current stimulationthe locus coeruleus-noradrenergic circuit

Outcome Measures

Primary Outcomes (1)

  • Change in working memory test scores after intervention.

    The working memory test consists of two parts, which measure the breadth and accuracy of working memory respectively. The breadth of working memory will be tested using the operating span experiment, as the accuracy of working memory will be tested using the Memory Orientation experiment.

    Baseline, 2-week, 2-month

Secondary Outcomes (2)

  • Change in three component test of executive function scores after intervention.

    Baseline, 2-week, 2-month

  • Change in the test of logical memory on the Wechsler Memory Test score after intervention.

    Baseline, 2-week, 2-month

Study Arms (2)

Active ON-tDCS

ACTIVE COMPARATOR

The active group will receive the active transcranial direct current stimulation via a saline-soaked pair of surface sponges. Patients received this treatment protocol for 5 consecutive days.

Device: Active ON-tDCS

Sham ON-tDCS

SHAM COMPARATOR

The sham group will also receive the transcranial direct current stimulation for 5 consecutive days on sham procedure. The rationale behind this sham procedure was to mimic the transient skin sensation at the beginning of active ON-tDCS without producing any conditioning effects on the brain.

Device: Sham ON-tDCS

Interventions

DC was transmitted via a saline-soaked pair of surface sponges and delivered by specially developed, battery-driven, constant current stimulator with a maximum output of 2 mA. For each participant receiving ON-tDCS, the anodal electrode placed over the left C2 nerve dermatome, and cathodal electrode placed over the right C2 dermatome. A constant current of 1.5 mA was applied for 20 min.

Active ON-tDCS

For sham group, placement of the electrodes was identical to that of active ON-tDCS. ON-tDCS was first switched on in a ramp-up fashion over 5 s. Current intensity (ramp down) was gradually reduced (over 5 s) as soon as ON-tDCS reached a current flow of 1.5 mA. Hence, sham ON-tDCS only lasted 10 s (as opposed to 20 min in the active group).

Sham ON-tDCS

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Eligible for ICD-10 depressive episode (F32) or recurrent depressive disorder (F33) diagnosis;
  • Antidepressant therapy for at least 8 weeks, with no antidepressant adjustment for nearly 2 months
  • HAMD-17 scores ≤ 7 points at the time of enrollment; CGI score ≦2;
  • Chief complaint of memory impairment, PDQ-D score of cognitive impairment ≧17 points;
  • Right-handed.

You may not qualify if:

  • A history of major physical diseases;
  • Have other mental disorders that meet the diagnostic criteria of ICD-10;
  • Hearing, color blindness, color weakness or receive electroconvulsive therapy;
  • Alcohol dependence or substance abuse;
  • Patients with intellectual disability;
  • Pregnant or lactating women or those planning to become pregnant;
  • Patients with contraindications to tDCS.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Zhejiang University

Hanzhou, Zhejiang, 310009, China

RECRUITING

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Central Study Contacts

Huang, Manli, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2022

First Posted

December 2, 2022

Study Start

October 1, 2022

Primary Completion

December 31, 2023

Study Completion

October 1, 2024

Last Updated

December 2, 2022

Record last verified: 2022-11

Locations